Sleeve gastrectomy facilitates weight loss and permits cardiac transplantation in patients with severe obesity and a left ventricular assist device (LVAD).
Catherine TsaiPatrick DolanNoah MossAlejandro F SandovalJulie RoldanDaniel M HerronPublished in: Surgical endoscopy (2023)
SG is a safe and effective operation in patients with severe obesity and heart failure requiring an LVAD. 66.7% of our cohort achieved target BMI < 35 and 33.3% underwent heart transplantation. Longer term follow-up is needed to clarify full bridge-to-transplant rate and long-term survival outcomes.
Keyphrases
- left ventricular assist device
- weight loss
- bariatric surgery
- heart failure
- weight gain
- roux en y gastric bypass
- insulin resistance
- metabolic syndrome
- gastric bypass
- left ventricular
- high fat diet induced
- early onset
- type diabetes
- body mass index
- preterm infants
- glycemic control
- cell therapy
- atrial fibrillation
- gestational age
- adipose tissue
- stem cells
- bone marrow
- physical activity
- skeletal muscle